Search results
Inotiv, Inc. Reschedules its Fiscal 2024 Second Quarter Results - Inotiv (NASDAQ:NOTV)
Benzinga· 10 hours agoInotiv, Inc. NOTV (the "Company"), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services ...
Sanofi's New Cancer Drug Could Help Deliver a Big Payday
Motley Fool via Yahoo Finance· 2 days agoSanofi (NASDAQ: SNY) believes it has a potential blockbuster in its innovative new cancer-fighting ...
Health Care Climbs as Obesity-Drug Optimism Returns - Health Care Roundup
Market Watch· 12 hours agoHealth-care companies rose as optimism about a boom in obesity drugs regained momentum. Novo Nordisk shares ticked up after the maker of obesity injection...
Oprah Sparks Controversy Speaking About Diet Culture Amid Ozempic Use
Parade via AOL· 10 hours agoThe TV personality stepped down from her position on the board of the company–which she held for...
The hell of drug pricing boards
Maryland Matters via Yahoo News· 22 hours agoJames K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against prescription drug affordability boards. The post The ...
Royalty Pharma pays startup $525M for stake in Sanofi MS drug
BioPharma Dive via Yahoo Finance· 21 hours agoThe deal gives the company milestone payments and royalties to a medicine, frexalimab, that Sanofi...
Company fined, placed on probation for misbranding veterinary drugs
Roanoke Times· 2 days agoCovetrus North American admitted that it illegally distributed the drugs to a variety of locations,...
New Jersey drug company to provide cash, naloxone to Delaware in latest opioid settlement
Delaware Online | The News Journal via Yahoo News· 4 days agoNew Jersey-based drug manufacturer Amneal Pharmaceuticals has become the latest company to reach a settlement agreement with Delaware and other states for ...
Novo Nordisk Partners With Metaphore Biotechnologies on New Obesity Drugs
Market Watch· 19 hours agoOzempic maker Novo Nordisk signed a research collaboration with U.S. biotech company Metaphore Biotechnologies to develop up to two advanced obesity treatments, which could ...
How Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 17 hours agoNeurocrine stock jumped nearly 5% on April 24, the day after thecompany unveiled the midstage test...